NAT1 and neoplasm: Importantly, the poor survival for patients with NAT1 negative tumors remained significant in a multivariate analysis when adjusting for node status, NHG, and tumor size (HR 2.8 (95% CI 1.0 to 7.2) P = 0.040; Table 2).